Medistim ASA (OSL:MEDI)
Norway flag Norway · Delayed Price · Currency is NOK
233.00
+3.00 (1.30%)
Apr 29, 2026, 2:07 PM CET

Medistim ASA Ratios and Metrics

Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,2074,7352,7413,9244,2366,699
Market Cap Growth
36.73%72.73%-30.14%-7.36%-36.77%46.13%
Enterprise Value
4,0454,5612,5873,7804,0936,587
Last Close Price
233.00259.00149.50214.00231.00367.50
PE Ratio
26.4129.7426.3737.7437.0273.80
Forward PE
27.0929.1025.3433.8039.9461.56
PS Ratio
6.016.774.877.468.6115.68
PB Ratio
8.9810.116.289.8611.5221.89
P/TBV Ratio
9.0910.116.279.8411.4821.91
P/FCF Ratio
23.1724.7220.0138.1740.6455.84
P/OCF Ratio
22.4924.7219.1632.9237.3252.59
EV/Sales Ratio
5.786.524.607.188.3215.42
EV/EBITDA Ratio
19.0621.4916.6324.3724.8847.15
EV/EBIT Ratio
20.6123.2519.7428.7528.9856.65
EV/FCF Ratio
22.2723.8118.8836.7739.2754.90
Debt / Equity Ratio
0.080.080.060.020.030.06
Debt / EBITDA Ratio
0.180.180.220.110.100.17
Debt / FCF Ratio
0.200.200.250.170.160.20
Net Debt / Equity Ratio
-0.37-0.37-0.33-0.34-0.37-0.34
Net Debt / EBITDA Ratio
-0.82-0.82-0.93-0.88-0.82-0.75
Net Debt / FCF Ratio
-0.91-0.91-1.06-1.32-1.30-0.88
Asset Turnover
1.131.131.041.071.111.14
Inventory Turnover
0.800.800.740.861.010.92
Quick Ratio
2.212.212.502.612.722.69
Current Ratio
3.343.344.004.153.873.95
Return on Equity (ROE)
35.18%35.18%24.88%27.12%33.83%23.68%
Return on Assets (ROA)
24.44%24.44%18.76%20.42%24.88%24.74%
Return on Invested Capital (ROIC)
36.54%36.54%28.77%31.92%38.94%35.57%
Return on Capital Employed (ROCE)
39.84%39.84%29.82%33.10%39.87%38.00%
Earnings Yield
3.78%3.36%3.79%2.65%2.70%1.36%
FCF Yield
4.32%4.05%5.00%2.62%2.46%1.79%
Dividend Yield
3.48%2.31%3.01%2.10%1.62%0.82%
Payout Ratio
68.76%68.76%79.37%79.15%60.01%60.11%
Buyback Yield / Dilution
0.21%0.21%-0.10%-0.11%-0.15%-0.07%
Total Shareholder Return
3.69%2.52%2.91%2.00%1.47%0.75%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.